Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Directory
Corporate Governance
Pipeline
Background - FAK
Background - Fibrotic Cancers
Background - Fibrosis
Our FAK Inhibitors
Investor Information
Welcome
Investor Fact Sheet
Investor Presentation
Research Reports
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Annual Reports
Half Yearly Reports
Quarterly Reports
Contact Us
Contact Us
Email Alerts
Investor Information
Home
>
Investor Information
>
Investor Presentation
Welcome
Investor Fact Sheet
Investor Presentation
Research Reports
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Investor Presentation
17-Dec-2019
Shareholder Update - December 2019
